Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects

• Status: Terminated
• Trial end date: 2016-08-01
• Target enrollment: 0
• Participant gender: Male

Summary

This is a brief inpatient study to determine the safety of a new drug in healthy people.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Colorado, Denver
• Collaborator: National Institute of Mental Health (NIMH)

Criteria

Inclusion Criteria:

• Healthy volunteer

Exclusion Criteria:

• Substance use. We do not accept inquiries by email.